Business
Flagship commits $50M to new startup that scours viral proteins for new drugs - Endpoints News
In the midst of the Covid-19 pandemic, while most scientists were busy plotting new ways to combat viruses, one startup quietly began a counterintuitive campaign: getting viruses to work for us, instead of against us. Now, after three years in stealt
By: Endpoints News
- May 08 2024
- 0
- 0 Views
In the midst of the Covid-19 panÂdemÂic, while most sciÂenÂtists were busy plotÂting new ways to comÂbat virusÂes, one startÂup quiÂetÂly beÂgan a counÂterÂinÂtuÂitive camÂpaign: getÂting virusÂes to… [+708 chars]